You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 1048 AB821 is a CD8+ T cell selective IL-21 with enhanced bioavailability that reduces CD8+ T cell exhaustion to induce potent antitumor activity

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1048 AB821 is a CD8+ T cell selective IL-21 with enhanced bioavailability that reduces CD8+ T cell exhaustion to induce potent antitumor activity

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023170014
Dec 20235008
Jan 20243103
Feb 20243403
Mar 20244007
Apr 20242002
May 20243002
Jun 20242400
Jul 20244403
Aug 20244204
Sep 20243801
Oct 202454010
Nov 20245605
Dec 20245207
Jan 202526010
Feb 2025603
Mar 2025009
Apr 2025006
May 2025006
Jun 2025004
Total7170107